Skip to Content

How is Ameluz used to treat actinic keratosis?

Answers (1)

Official Answer by 1 Jun 2016

Ameluz (generic name: BF-200 ALA) is Biofrontera’s topical prescription drug used with BF-RhodoLED photodynamic therapy (PDT) for treatment of mild to moderate actinic keratosis on the face and scalp.

An Actinic keratosis is a rough, scaly area of the skin due to years of sun exposure. Actinic keratosis, if left untreated, can develop into squamous cell carcinoma, a potentially fatal skin disease with rapidly growing incidence.

Ameluz gel is applied to the lesions by your doctor, and then covered with a light blocking, occlusive dressing for three hours. After that time the gel is removed, and the area is illuminated with BF-RhodoLED red light. Ameluz increases photosensitivity, an immune system reaction that is triggered by sunlight. Therefore, patients should avoid exposure to sunlight, prolonged or intense light (such as tanning beds, sun lamps) for 48 hours following treatment.

Ameluz is already approved and marketed in Europe and U.S. launch is expected in September 2016. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 13 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 10 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 10 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 9 days ago 1 answerFAQ by